why choose us

First received: January 03, 2024

Clinical Trial: Sarcopenia in Head and Neck Cancer Patients Treated with Curative Hadrontherapy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Head and Neck Cancer

Study Type: OBSERVATIONAL


Official Title: Role of Baseline Sarcopenia in Determining Acute Toxicity for Head and Neck Cancer Patients Treated with Curative Hadrontherapy: a Prospective Monoinstitutional Study

Brief Summary: The study focuses on the impact of sarcopenia on acute and late toxicities in head and neck tumor affected patients treated with particle therapy.

Read more